What is Tyzeka
Approved as Treatment by the FDATelbivudine, also known as Tyzeka, is approved by the FDA for 1 uses including Chronic Hepatitis B Infection .
When to interrupt dosageThe appropriate dosage of Tyzeka is contingent upon the diagnosed affliction. The amount of dosage also varies as per the administration technique (e.g. Tablet, film coated - Oral or Oral) recorded in the table below.
WarningsTyzeka has two counter-indications. Under no circumstances should it be taken in combination with the conditions listed in the table below.Tyzeka Contraindications
Tyzeka Novel Uses: Which Conditions Have a Clinical Trial Featuring Tyzeka?Three active clinical trials are assessing the potential of Tyzeka to alleviate Chronic Hepatitis B.
Patient Q&A Section about tyzekaThese questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How long can hepatitis B be treated?
"Hepatitis B infection may be acute (short-lived) or chronic (long-lasting). Acute hepatitis B infection lasts less than six months and usually goes away on its own."
Why was telbivudine discontinued?
"Telbivudine was approved by the United States in 2006 to be used as a therapy for chronic hepatitis B, either by itself or with other agents. It was withdrawn from the United States market in 2016 for mostly economic reasons. Telbivudine was previously accessible as 600 mg tablets under the brand name Tyzeka."
What kind of drug is telbivudine?
"Telbivudine is used to treat chronic hepatitis B infection by reducing the amount of hepatitis B virus in the body. It is part of a class of medications called nucleoside analogues."
What is tyzeka used for?
"Tyzeka is a medication used to treat an active, chronic hepatitis B infection. It is a nucleoside reverse transcriptase inhibitor (NRTI). NRTIs work by inserting themselves into the virus' DNA (genetic material)."